Mona Ståhle Selected Research

HLA-C Antigens (HLA-C)

1/2020	Interaction between Smoking and HLA-C*06:02 on the Response to Ustekinumab in Psoriasis.
8/2015	Association with Genetic Variants in the IL-23 and NF-κB Pathways Discriminates between Mild and Severe Psoriasis Skin Disease.
2/2013	Genetic association with ERAP1 in psoriasis is confined to disease onset after puberty and not dependent on HLA-C*06.
3/2012	Cost-effective HLA-Cw06:02 typing in a Caucasian population.
11/2010	A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1.
5/2009	HLA-Cw*0602 associates with a twofold higher prevalence of positive streptococcal throat swab at the onset of psoriasis: a case control study.
7/2008	IFN-regulatory factor 5 gene variants interact with the class I MHC locus in the Swedish psoriasis population.
2/2007	HLA-C expression pattern is spatially different between psoriasis and eczema skin lesions.
10/2005	Distinct HLA-C/KIR genotype profile associates with guttate psoriasis.
1/2005	HLA-Cw*0602 associates more strongly to psoriasis in the Swedish population than variants of the novel 6p21.3 gene PSORS1C3.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mona Ståhle Research Topics

Disease

45	Psoriasis (Pustulosis Palmaris et Plantaris) 03/2022 - 01/2005
13	Inflammation (Inflammations) 01/2018 - 04/2006
7	Skin Diseases (Skin Disease) 03/2022 - 04/2006
7	Wounds and Injuries (Trauma) 01/2021 - 08/2015
6	Neoplasms (Cancer) 01/2018 - 05/2005
4	Atopic Dermatitis (Atopic Eczema) 01/2021 - 07/2007
4	Ulcer 12/2017 - 04/2010
4	Infections 06/2014 - 01/2005
3	Melanoma (Melanoma, Malignant) 10/2019 - 03/2016
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 10/2019 - 08/2012
2	Basal Cell Carcinoma (Rodent Ulcer) 10/2019 - 04/2013
2	Rosacea (Acne Rosacea) 01/2018 - 03/2016
2	Acne Vulgaris 01/2018 - 03/2016
2	Eczema 05/2013 - 02/2007
2	Breast Neoplasms (Breast Cancer) 01/2009 - 05/2005
1	Mycoses (Diseases, Fungus) 03/2022
1	Oral Candidiasis (Thrush) 03/2022
1	Pemphigus (Pemphigus Vulgaris) 12/2021
1	Autoimmune Diseases (Autoimmune Disease) 12/2021
1	Psoriatic Arthritis 07/2021
1	Disease Progression 04/2021
1	Arthralgia (Joint Pain) 04/2021
1	Hypoxia (Hypoxemia) 12/2020
1	Varicose Ulcer (Ulcer, Venous) 01/2020
1	Skin Neoplasms (Skin Cancer) 10/2019
1	Neoplasm Metastasis (Metastasis) 01/2018
1	Liver Cirrhosis (Hepatic Cirrhosis) 08/2017
1	Vitiligo 01/2017
1	Cachexia 01/2015

Drug/Important Bio-Agent (IBA)

17	MicroRNAs (MicroRNA)IBA 01/2021 - 07/2007
10	HLA-C Antigens (HLA-C)IBA 01/2020 - 01/2005
8	Proteins (Proteins, Gene)FDA Link 01/2018 - 01/2005
6	CytokinesIBA 03/2022 - 01/2013
5	Interleukin-17 (Interleukin 17)IBA 03/2022 - 01/2017
5	ChemokinesIBA 01/2019 - 01/2013
5	Biological ProductsIBA 01/2018 - 01/2013
5	Messenger RNA (mRNA)IBA 07/2015 - 01/2009
4	CathelicidinsIBA 05/2010 - 05/2005
3	Interleukin-23 (Interleukin 23)IBA 04/2021 - 08/2015
3	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2018 - 03/2016
2	InterleukinsIBA 03/2022 - 03/2016
2	Biomarkers (Surrogate Marker)IBA 12/2021 - 01/2014
2	Methotrexate (Mexate)FDA LinkGeneric 10/2019 - 08/2017
2	Long Noncoding RNAIBA 01/2019 - 01/2019
2	Granzymes (Granzyme)IBA 01/2017 - 01/2017
2	Interleukin-22 (IL-22)IBA 01/2017 - 06/2014
2	Amino Acids FDA Link 01/2015 - 01/2005
2	Antimicrobial PeptidesIBA 05/2010 - 04/2005
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 05/2005 - 04/2005
1	apremilastIBA 01/2022
1	AutoantigensIBA 12/2021
1	AutoantibodiesIBA 12/2021
1	HLA-B Antigens (HLA-B)IBA 07/2021
1	beta-apocarotenoid-14',13'-dioxygenase (ADO)IBA 01/2021
1	ChromatinIBA 01/2021
1	Ustekinumab (CNTO 1275)FDA Link 01/2020
1	Janus KinasesIBA 08/2018
1	tofacitinibIBA 08/2018
1	Janus Kinase InhibitorsIBA 08/2018
1	Serum Amyloid A Protein (Serum Amyloid A)IBA 01/2018
1	Poloxamer (Poloxamer 407)IBA 12/2017
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2017
1	NLR ProteinsIBA 12/2017
1	Liposomes (Liposome)IBA 12/2017
1	Leptin ReceptorsIBA 12/2017
1	PerforinIBA 01/2017
1	Carrier Proteins (Binding Protein)IBA 01/2017
1	Imiquimod (Aldara)FDA LinkGeneric 01/2017
1	Transcription Factors (Transcription Factor)IBA 12/2016
1	ApelinIBA 03/2016
1	AdiponectinIBA 03/2016
1	ResistinIBA 03/2016
1	LeptinIBA 03/2016
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 03/2016
1	AdipokinesIBA 03/2016
1	Nicotinamide PhosphoribosyltransferaseIBA 03/2016
1	Plasminogen Activator Inhibitor 1IBA 03/2016
1	Retinol-Binding Proteins (Retinoid Binding Proteins)IBA 03/2016
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 03/2016
1	Isotretinoin (Accutane)FDA LinkGeneric 03/2016
1	ixekizumabIBA 01/2016
1	interleukin-21 (interleukin 21)IBA 08/2015
1	SphingolipidsIBA 07/2015
1	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 07/2015
1	CeramidesIBA 07/2015
1	Threonine (L-Threonine)FDA Link 01/2015
1	Arginine (L-Arginine)FDA Link 01/2015
1	Aspartic Acid (Aspartate)FDA Link 01/2015
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 01/2015
1	Pharmaceutical PreparationsIBA 01/2015
1	CollagenIBA 01/2015
1	Serine (L-Serine)FDA Link 01/2015
1	Etanercept (Enbrel)FDA Link 01/2015
1	Alanine (L-Alanine)FDA Link 01/2015
1	Glutamic Acid (Glutamate)FDA Link 01/2015
1	Proline (L-Proline)FDA Link 01/2015

Therapy/Procedure

9	Therapeutics 03/2022 - 10/2010
1	Oral Hygiene (Dental Hygiene) 03/2022
1	Phototherapy (Light Therapy) 10/2019
1	Biological Therapy 10/2019